Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
64°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.49
+0.18 (+0.61%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
Renewable Energy Investment Market Size, Share, Trends, Industry Growth, and Forecast 2028 Top Key Players Spectrum, Roche, Pfizer, Novartis, Merck, Bayer, Healthcare Amgen
March 01, 2022
Renewable Energy Investment Market Size, Share, Growth, Industry Trends, Business Scope, Global Providers, COVID-19 Impact and Forecast 2028
Via
SBWire
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 1, 2022 – Last year was a monumental year for merger and acquisition activity. Records worldwide weren’t just broken, they were smashed by M&A...
Via
FinancialNewsMedia
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 28, 2022
From
Pfizer Inc.
Via
Business Wire
mRNA Vaccines in Medical Engineering Cancer Treatment
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way...
Via
SBWire
Exposures
COVID-19
Pfizer Invests $68.5 Million in New Pharma R&D Facility
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this...
Via
SBWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
February 22, 2022
From
Pfizer Inc.
Via
Business Wire
U C, Inc., SMMR, Appoints New Board Member and CEO
February 21, 2022
U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of...
Via
Newswire.com
Topics
Stocks
Exposures
US Equities
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
February 11, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
February 08, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
February 01, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces New Chief Development Officer
February 01, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and AWS Working Together to Speed Up Clinical Operations Trials
January 28, 2022
New York, NY -- (SBWIRE) -- 01/28/2022 -- Technology is vital to optimizing the process of clinical operations trials in the near future - and this has been brought one step closer by the news that...
Via
SBWire
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
January 28, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
January 27, 2022
From
Pfizer Inc.
Via
Business Wire
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
January 27, 2022
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,...
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
January 25, 2022
From
Pfizer Inc.
Via
Business Wire
Dietary Supplements Market Growing at a CAGR of 7.0% | Key Players are Amway, Herbalife Nutrition, ADM, Pfizer, Abbott Laboratories, Bayer, Glanbia, Nature’s Sunshine Products
January 24, 2022
Via
AB Newswire
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
January 21, 2022
From
Pfizer Inc.
Via
Business Wire
Promising Research in Fight Against Breast Cancer Being Amplified by an Active Biotech Sector
January 20, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 20, 2021 – USA News Group – As the 2021 San Antonio Breast Cancer Symposium (SABCS) comes to a close, many of this year’s...
Via
FinancialNewsMedia
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
New York, NY, and Tel Aviv, ISRAEL - (NewMediaWire) - January 18, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released videos of...
Via
NewMediaWire
Exposures
COVID-19
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
January 14, 2022
From
Pfizer Inc.
Via
Business Wire
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
January 14, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 14, 2022 – USA News Group – Cancer cases are on the rise, according to a new study comparing the number of cancer...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
DGE’s Investigator Initiated Trials Summit
January 14, 2022
Via
Investor Brand Network
Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released
January 12, 2022
From
Pfizer Inc.
Via
Business Wire
With Full Enrollment Complete In Its Phase 2 COVID-Related GI Treatment Trial, First Wave Bio Could Earn An EUA Sooner Than Later (NASDAQ: FWBI)
January 11, 2022
Via
AB Newswire
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.